An estimate of the prevalence of COPD in Africa: A systematic analysis

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 1, 2015, Pages 71-81

  Adeloye, Davies ^a   Basquill, Catriona ^a   Papana, Angeliki ^b   Chan, Kit Yee ^a   Rudan, Igor ^a   Campbell, Harry ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MACEDONIA   (Greece)

Author keywords

Africa; Chronic bronchitis; Chronic obstructive; COPD; Prevalence; Pulmonary disease

Indexed keywords

AFRICA; AFRICAN; AGE DISTRIBUTION; AGING; ATTRIBUTABLE RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMBASE; HEALTH; HEALTH CARE POLICY; HUMAN; INTERNAL CONSISTENCY; MEDLINE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SEX RATIO; SPIROMETRY; SYSTEMATIC REVIEW; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AFRICA; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 84923078785     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.908834     Document Type: Review

References (66)

1. WHO. The global burden of disease: 2004 update. Geneva: WHO, 2008.
2. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P. The Lancet NCD Action Group and the NCD Alliance. Priority actions for the non-communicable disease crisis. Lancet. 2011; 377:1438-1447.
3. Musafiri S, Joos G, Van Meerbeeck JP. Asthma, atopy and COPD in sub-Saharan countries: the challenges. East Afr J Publ Health. 2011; 8(2):161-163.
4. Chan KY, Adeloye D, Grant L, Kolčić I, Marušć A. How big is the 'next big thing'? Estimating the burden of non-communicable diseases in low- and middle-income countries. J Glob Health. 2012; 2(2):20101.
5. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2197-2223.
6. Ait-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Org 2001; 79(10):971-979.
7. Chermiti Ben Abdallah F, Taktak S, Chtourou A, Mahouachi R, Ben Kheder A. Burden of chronic respiratory diseases (CRD) in middle east and North Africa (MENA). World Allergy Organization J 2011; 4 (SUPPL. 1):S6-S8.
8. WHO. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization, 2011.
9. Chan-Yeung M, Ait-Khaled N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Inter J Tuberculosis Lung Dis 2004; 8 (1):2-14.
10. van Gemert F, van der Molen T, Jones R, Chavannes N. The impact of asthma and COPD in sub-Saharan Africa. Primary Care Respir J 2011 Sep; 20(3):240-248.
11. Mehrotra A, Oluwole AM, Gordon SB. The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa. Trop Med Inter Health 2009 Aug; 14(8):840-848.
12. Finney LJ, Feary JR, Leonardi-Bee J, Gordon SB, Mortimer K. Chronic obstructive pulmonary disease in sub-Saharan Africa: a systematic review. Int J Tuberc Lung Dis 2013; 17(5):583-589.
13. Stanciole AE, Ortegon M, Chisholm D, Lauer JA. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012; 344:e608.
14. El Hasnaoui A, Rashid N, Lahlou A, Salhi H, Doble A, Nejjari C. Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: Rationale and design of the BREATHE study. Respiratory Medicine. 2012; 106 (SUPPL. 2):S3-S15.
15. IU ATLD. The Global Asthma Report 2011. Paris, France: The International Union Against Tuberculosis and Lung Disease; 2011.
16. Abdool-Gaffar MS, Ambaram A, Ainslie GM, Bolliger CT, Feldman C, Geffen L, et al. Guideline for the management of chronic obstructive pulmonary disease - 2011 update. S Afr Med J. 2011; 101(1 Pt 2):63-73.
17. Aisanov Z, Bai C, Bauerle O, Colodenco FD, Feldman C, Hashimoto S, et al. Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Inter J COPD 2012; 7:271-282.
18. Gjevre JA, Hurst TS, Taylor-Gjevre RM, Cockcroft DW. The American Thoracic Society's spirometric criteria alone is inadequate in asthma diagnosis. Can Respir J 2006; 13(8):433-437.
19. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Euro Respir J 2007; 30(5):993-1013.
20. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Revised. 2011 [23 April 2012]; Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf.
21. ERS-ATS. ERS-ATS COPD Guidelines. Switzerland: European Respiratory Society; 2005 [25 May 2012]; Available from: www.ersnet.org.
22. World Bank. World Bank List of Economies (July 2012)2012: Available from: http://librarians.acm.org/sites/default/files/world%20bank%20List%20of%20Economies%20%28as%20of%20July%202012%29.pdf.
23. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370(9589):741-750.
24. Desalu OO. Prevalence of chronic bronchitis and tobacco smoking in some rural communities in Ekiti state, Nigeria. Niger Postgrad Med J 2011; 18(2):91-97.
25. Desalu OO, Adekoya AO, Ampitan BA. Increased risk of respiratory symptoms and chronic bronchitis in women using biomass fuels in Nigeria. J Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia 2010; 36(4):441-446.
26. Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, et al. Predictors of chronic bronchitis in South African adults. Inter J Tuberculosis Lung Dis 2004; 8(3):369-376.
27. Fullerton DG, Suseno A, Semple S, Kalambo F, Malamba R, White S, et al. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Inter J Tubercul Lung Dis 2011 Mar; 15(3):391-398.
28. Gathuru IM, Bunker CH, Ukoli FA, Egbagbe EE. Differences in rates of obstructive lung disease between Africans and African Americans. Ethnic Dis 2002; 12(4):S3-107-113.
29. Khelafi R, Aissanou A, Tarsift S, Skander F. [Epidemiology of chronic obstructive pulmonary disease in Algiers]. Revue Maladies Respir 2011; 28(1):32-40.
30. Musafiri S, van Meerbeeck J, Musango L, Brusselle G, Joos G, Seminega B, et al. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country. Respir Med 2011; 105(11):1596-1605.
31. Girdler-Brown BV, White NW, Ehrlich RI, Churchyard GJ. The burden of silicosis, pulmonary tuberculosis and COPD among former Basotho goldminers. Amer J Indust Med 2008; 51(9):640-7.
32. Laraqui Hossini CH, Laraqui Hossini O, Rahhali AE, Tripodi D, Caubet A, Belamallem I, et al. Respiratory symptoms and ventilatory disorders among a group of cement workers in Morocco. [French]. Revue Maladies Respir 2002; 19 (2 I):183-189.
33. Ayo-Yusuf OA, Reddy PS, van den Borne BW. Association of snuff use with chronic bronchitis among South African women: implications for tobacco harm reduction. Tob Control 2008; 17(2):99-104.
34. Mengesha YA, Bekele A. Relative chronic effects of different occupational dusts on respiratory indices and health of workers in three Ethiopian factories. Am J Ind Med 1998; 34(4):373-380.
35. Tabka F, Mrizek N, Tabka Z, Choudat D, Conso F. [Respiratory diseases related to cereal dust exposure in Tunisia]. Archives des maladies professionnelles et de médecine du travail. 1999; 60:101-106.
36. Burney P. The Burden of Obstructive Lung Disease (BOLD) study prepares for African Surveys. Africa Health 2011; 33(2)12.
37. Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, Chifamba J, et al. Emerging Non-communicable Disease Epidemic in Africa: Preventive Measures from the WHO Regional Office for Africa. Georgia: International Society on Hypertension in Blacks.
38. Silva-Matos C, Beran D. Non-communicable diseases in Mozambique: Risk factors, burden, response and outcomes to date. Globalization and Health. 2012; 8(37).
39. Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J. 2010 Nov; 36(5):1034-41.
40. Martins P, Rosado-Pinto J, do Ceu Teixeira M, Neuparth N, Silva O, Tavares H, et al. Under-report and underdiagnosis of chronic respiratory diseases in an African country. Allergy 2009; 64(7):1061-1067.
41. Menezes A, Macedo SC, Gigante DP, da Costa JD, Olinto MT, Fiss E, et al. Prevalence and risk factors for chronic obstructive pulmonary disease according to symptoms and spirometry. COPD 2004; 1(2):173-179.
42. Talamo C, de Oca MM, Halbert R, Perez-Padilla R, Jardim JR, Muino A, et al. Diagnostic labeling of COPD in five Latin American cities. Chest 2007; 131(1):60-67.
43. Jagoe K, Edwards R, Mugusi F, Whiting D, Unwin N. Tobacco smoking in Tanzania, East Africa: population based smoking prevalence using expired alveolar carbon monoxide as a validation tool. Tob Control 2002; 11(3): 210-214.
44. Jha P, Ranson MK, Nguyen SN, Yach D. Estimates of Global and Regional Smoking prevalence in 1995, by Age and Sex. Am J Public Health 2002; 92(6):1002-1006.
45. Townsend L, Flisher AJ, Gilreath T, King G. A systematic literature review of tobacco use among adults 15 years and older in sub-Saharan Africa. Drug Alcohol Depend 2006; 84(1):14-27.
46. Pampel F. Tobacco use in sub-Saharan Africa: estimates from the demographic health surveys. Soc Sci Med 2008; 66(8):1772-1783.
47. Chatila WM, Wynkoop WA, Vance G, Criner GJ. Smoking patterns in African Americans and whites with advanced COPD. Chest 2004; 125(1):15-21.
48. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859):2095-2128.
49. Fan V, Lam F. Malaria Estimate Sausages by WHO and IHME. Washington DC, USA: Centre for Global Development; 2012 [cited 2013 22 June]; Available from: http://www.cgdev.org/blog/malaria-estimate-sausages-who-and-ihme.
50. Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Degenhardt L. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010? Curr Opin Psych 2013; 26(4):376-383.
51. Boschetto P, Quintavalle S, Miotto D, Lo Cascio N, Zeni E, Mapp CE. Chronic obstructive pulmonary disease (COPD) and occupational exposures. J Occup Med Toxicol 2006; 1:11.
52. Barnes PJ. Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic. PLoS Med 2007; 4(5):e112.
53. Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010; 126(5):926-938.
54. Otañez MG, Mamudu HM, Glantz SA. Tobacco companies' use of developing countries' economic reliance on tobacco to lobby against global tobacco control: the case of Malawi. Am J Public Health 2009; 99(10):1759-1771.
55. Saloojee Y, Dagli E. Tobacco industry tactics for resisting public policy on health. Bull World Health Organ 2000; 78(7):902-910.
56. Kiraz K, Kart L, Demir R, Oymak S, Gulmez I, Unalacak M, et al. Chronic pulmonary disease in rural women exposed to biomass fumes. Clinical & Investigative Medicine - Medecine Clinique et Experimentale. [Comparative Study]. 2003; 26(5):243-248.
57. WHO. Global surveillance, prevention and control of Chronic Respiratory Diseases: A comprehensive approach. Geneva: WHO; 2007. Available from: http://www.who.int/gard/publications/GARD_Manual/en/index.html.
58. Pronyk RM, Makhubele MB, Hargreaves JR, Tollman SM, Hausler HP. Assessing health seeking behaviour among tuberculosis patients in rural South Africa. Int J Tuberc Lung Dis 2001; 5(7):619-627.
59. Laraqui CH, Caubet A, Laraqui O, Benghalem A, Harourate K, Bichara M, et al. [Prevalence of respiratory systems and evaluation of sensitization levels in traditional grain market workers in Casablanca]. Rev Mal Respir 2000; 17(5):947-955.
60. Ait-Khaled N, Enarson DA, Ottmani S, El Sony A, Eltigani M, Sepulveda R. Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis 2007; 2(2):141-150.
61. Poyser MA, Nelson H, Ehrlich RI, Bateman ED, Parnell S, Puterman A, et al. Socioeconomic deprivation and asthma prevalence and severity in young adolescents. Euro Respir J [Research Support, Non-U.S. Gov't]. 2002; 19(5):892-898.
62. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, et al. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 2011; 139 (4):752-763.
63. de-Graft Aikins A, Boynton P, Atanga LL. Developing effective chronic disease interventions in Africa: Insights from Ghana and Cameroon. Global Health 2010; 6(6).
64. Erhabor GE, Kolawole OA. Chronic obstructive pulmonary disease: a ten-year review of clinical features in O.A.U.T.H.C., Ile-Ife. Niger J Med 2002; 11(3):101-104.
65. Sitas F, Urban M, Bradshaw D, Kielkowski D, Bah S, Peto R. Tobacco attributable deaths in South Africa. Tobacco Cont 2004; 13(4):396-399.
66. Adejuwon GA. Tobacco use and second hand smoke as risk factors for diseases in Nigeria: implications for collaborative research and multilevel tobacco control strategies. Afr J Med Med Sci 2009; 38 Suppl 2:21-29.